SEC EDGARAUG 122 min read$CGNX

Moschner Matthew sold $1.6M of CGNX

Moschner Matthew (CEO & President) sold 24,962 shares of COGNEX CORP (CGNX) at an average of $64.01 ($63.61–$65.36, $1.60M total) across 5 trades on 2026-08-11 under a Rule 10b5-1 trading plan.

Original reporting

SEC EDGAR · Moschner Matthew

Published Aug 12, 2026, 8:00 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Aug 12, 2026, 8:03 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$CGNX

Neutral

medium confidence

Mentioned

$CGNX

Relevance

5/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$CGNXNeutralLow

Why it matters

The disclosure updates the record of insider activity and may influence short-term sentiment, but it does not provide new operational, financial, or regulatory information about Cognex.

Market read

A $1.60M CEO sale is disclosed, but the 10b5-1 framing suggests limited fundamental implications.

What to watch

Because the trades are explicitly under a pre-arranged 10b5-1 plan, the sale may reflect scheduled liquidity rather than a view on near-term fundamentals.

Relevance 5/10Novelty 3/10Timing: SEC Form 4 filed 2026-08-12, covering sales executed 2026-08-11

Background

The article is an SEC Form 4 insider transaction disclosure for Cognex (CGNX) by CEO and President Matthew Moschner.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$CGNXNeutralMedium confidence

Context

Cognex CEO and President Moschner Matthew sold about 24,962 shares in open-market trades totaling $1.60M, per a new SEC Form 4 filed today.

Expected impact

Likely limited near-term impact; any reaction should be muted unless traders treat the sale as a sentiment read-through.

Evidence & confidence

The filing specifies a Rule 10b5-1 pre-arranged plan and an open-market sale by the CEO, which typically reduces the likelihood of immediate fundamental news.

Market effects

Sector

No direct sector read-through; insider sales under 10b5-1 are generally not sector-moving.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Traders may still interpret a CEO sale as a bearish sentiment signal, especially if it coincides with other negative company-specific catalysts not mentioned here.

Key entities

equity issuer
CGNX
Cognex Corp, the issuer of the insider transaction disclosed on Form 4.
insider
Matthew Moschner
CEO and President who sold shares in open-market transactions under a pre-arranged 10b5-1 plan.

Read at source ← All news

SEP 5

$CGNXMedAI 8/10

Cognex (CGNX) Lifted Revenue Guidance, Is The Stock Already Pricing In The Upside?

Cognex (CGNX) reported Q2 revenue growth and raised guidance, exceeding expectations. Despite a recent 11.96% share price pullback, the stock is up 68.56% year-to-date. Analysts expect earnings to reach $373.0 million by August 2029, with a fair value estimate of $80.42, suggesting a 23% undervaluation. However, the stock's high P/E ratio of 59.9x raises valuation concerns.

simplywall.st2 min

SEP 3

$MIRMed

Q2 Earnings Highlights: OSI Systems (NASDAQ:OSIS) Vs The Rest Of The Specialized Technology Stocks

Napco (OSIS) reported Q2 revenue of $55.81M, up 10% YoY, beating estimates. Mirion (MIR) reported $266.8M, up 19.7%, missing expectations. Crane NXT (CXT) reported $493.2M, up 22%, in line with estimates. Cognex (CGNX) reported $291.3M, up 16.9%, missing slightly. All stocks declined post-earnings.

finance.yahoo.com3 min

SEP 3

$CGNXMed

Reflecting On Specialized Technology Stocks’ Q2 Earnings: Cognex (NASDAQ:CGNX)

Cognex (CGNX) reported Q2 revenue of $291.3M, up 16.9% YoY, missing estimates by 0.7%. Despite strong guidance, its stock fell 15.1%. Specialized tech stocks collectively beat revenue estimates by 1.4% but declined 2.3% on average. Other companies mentioned: NSSC, OSIS, PAR, ZBRA.

tradingview.com3 min

AUG 21

$AMBAMedAI 8/10

Usain Bolt Just Got an AI Rival – Meet the Stocks Behind It

Unitree Robotics, a Chinese company, unveiled a humanoid robot 'Superman' claiming it runs faster than Usain Bolt. The company's IPO on the Shanghai Stock Exchange saw shares surge 460%, valuing it at $50 billion. Investors are betting on the humanoid robotics sector and its supply chain, including companies like Ambarella, Ouster, Cognex, Regal Rexnord, and Harmonic Drive Systems, which saw gains in July.

investorplace.com3 min

AUG 21

$CGNXHighAI 8/10

Enabled Machine Vision Drives Growth – Metrology and Quality News

Cognex Corporation reported record Q2 2026 revenue of $291M, up 17% YoY, driven by demand across major markets and AI-enabled vision applications. Profitability improved significantly, with operating income doubling to $86M and operating margin increasing to 29.4%. The company highlighted the launch of OneVision, its AI-powered machine vision platform, and reaffirmed its growth strategy focused on diversification and scalability. Cognex issued full-year 2026 guidance for strong double-digit reve

metrology.news2 min

AUG 13

$CGNXMedAI 9/10

Cognex (CGNX) Q2 2026 Earnings Call Transcript

Cognex (CGNX) reported Q2 2026 revenue of $291 million, up 17% (16% constant currency). Adjusted EBITDA margin rose to 32.2%, and adjusted EPS was $0.45. Full-year 2026 guidance: revenue $1.13 to $1.15 billion, adjusted EPS $1.64 to $1.68, and adjusted EBITDA margin 29% to 31%. Management raised outlooks for logistics, packaging, electronics, and semiconductors.

fool.com6 min